Skip to main content icon/video/no-internet

Flat-of-the-curve medicine refers to applications of healthcare resources yielding no discernable or valuable health benefits. It is a level of intensity of healthcare that provides no incremental benefit. In health economic terms, it is the consumption of medical care resources to a point that the marginal (added) benefit relative to the marginal (added) cost is at or near zero. Flat-of-the-curve medicine is of concern because it affects the cost and quality of healthcare without improving health and medical outcomes. It also has implications for issues of access, financing, reimbursement, and the organization of healthcare. Under standing this concept, why it occurs, and how it might be addressed is beneficial to health services researchers and healthcare policymakers.

Variation in the use of healthcare and health outcomes in the United States is ubiquitous. Variation in the amount of healthcare delivered has been noted many times in seemingly comparable patients in terms of their health status and social demographic characteristics and the type and depth of health insurance coverage. This observation has persisted over time. Concern has been expressed that patients receiving costly high-intensity healthcare often do not have better health outcomes than those receiving cheaper low-intensity care. This finding is not confined to the United States. The same phenomenon has been observed in other highly developed nations. This has led some researchers to conclude that differences in the intensity of healthcare play, at most, a minor role in explaining cross-sectional differences in health outcomes. Many health services researchers and healthcare policymakers have termed this phenomenon flat-of-the-curve medicine.

What is Flat-of-the-Curve Medicine?

Popularized by health economists such as Alain Enthoven, Robert Evans, and Victor Fuchs, the concept underlying flat-of-the-curve medicine is analogous to the economic law of diminishing marginal returns; that is, as inputs are applied to a production process in successively larger amounts, there will be successively smaller increases in outputs. At some point, additional inputs may result in zero or even negative outputs. Used frequently in economics, this law has been applied in many instances to the production of many goods and services, environment, energy production, national defense, and medicine.

Figure 1 shows a theoretical curve to explain the concept of flat-of-the-curve medicine. An example would be the length of an inpatient hospital stay for a patient with a particular diagnosis. The horizontal x-axis in the figure reflects the inputs—in this case, cost in dollars for each day. These costs may be for personnel, equipment, supplies, overhead, and so on. The vertical y-axis reflects health outcomes depicted by improved health status. Each letter (A, B, C, D, and E) represents one inpatient hospital day. The first inpatient day (A) is clearly beneficial. Likewise, the second inpatient day (B) is beneficial but less so. Inpatient Day C is beneficial but less so than either of the previous days. That is, there is an added (marginal) benefit relative to the added (marginal) cost after the first inpatient day, but this benefit accrues at a diminishing rate. Finally, Inpatient Day 4 (D) and Inpatient Day 5 (E) add marginal costs but no discernable marginal benefit. In this instance, the marginal benefit after the third inpatient day relative to costs is zero. Likewise, additional inpatient days beyond C would add only costs without any concomitant benefits.

...

  • Loading...
locked icon

Sign in to access this content

Get a 30 day FREE TRIAL

  • Watch videos from a variety of sources bringing classroom topics to life
  • Read modern, diverse business cases
  • Explore hundreds of books and reference titles

Sage Recommends

We found other relevant content for you on other Sage platforms.

Loading